The primary purpose of the protocol is to evaluate the StO2 performance measured at the admission to the emergency department to identify hemodynamic failure at the admission or within the first three hours of monitoring patients with drug poisoning. The study hypotheses are: * The early detection of hypoperfusion by StO2, essential to prevent the development of collapse. * To limit hemodynamic failure effects, reduce morbidity and mortality of drug poisoning, hospital stay and cost.
The procedure is a measurement and non-invasive monitoring system of percentage of oxygen saturation of haemoglobin in tissues using infrared technology. The system used in the study is the tissue oxygenation monitor InSpectraTM StO2 Spot Check, Model 300 consisting of a clamp applied to the base of the thumb of the patient.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
300
The procedure is a measurement and non-invasive monitoring system of percentage of oxygen saturation of haemoglobin in tissues using infrared technology. The system used in the study is the tissue oxygenation monitor InSpectraTM StO2 Spot Check, Model 300 consisting of a clamp applied to the base of the thumb of the patient.
University Hospital of Toulouse
Toulouse, Midi-Pyrenees, France
StO2 performance measured to identify hemodynamic failure.
Time frame: Outcome measure is assessed during three hours after the admission to the emergency department.
StO2 distribution
Time frame: Outcome measure is assessed during three hours after the admission to the emergency department.
StO2 threshold value to predict the onset of hemodynamic failure
Time frame: Outcome measure is assessed during three hours after the admission to the emergency department.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.